世界の顔用注射剤市場2021-2028:製品別(コラーゲン、ヒアルロン酸、ボツリヌス毒素タイプA、ハイドロキシアパタイトカルシウム、ポリマーフィラー)、用途別、地域別

◆英語タイトル:Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC123
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月29日
◆ページ数:172
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の顔用注射剤市場規模が2028年までに277億ドルに達すると予測しています。2021年から2028年までに年平均8.8%成長する見通しです。本調査レポートでは、顔用注射剤の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別(コラーゲン、ボツリヌス毒素A型、ヒアルロン酸、ハイドロキシアパタイトカルシウム、ポリマーフィラー)分析、用途別(美容、治療)分析、地域別分析、競争分析などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・顔用注射剤の世界市場規模:製品別(コラーゲン、ボツリヌス毒素A型、ヒアルロン酸、ハイドロキシアパタイトカルシウム、ポリマーフィラー)
・顔用注射剤の世界市場規模:用途別(美容、治療)
・顔用注射剤の世界市場規模:地域別
・競争分析
【レポートの概要】

Facial Injectable Market Growth & Trends

The global facial injectable market size is expected to reach USD 27.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectables include hyaluronic acid, botulinum toxin type A, and polymer fillers.

The growing focus on physical appearance, especially in developing countries, is one of the key factors expected to drive the market. In addition, a shift in consumer preference toward minimally invasive procedures is expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the middle-class population, backed by increasing disposable income.

With non-urgent and cosmetic surgeries being put on hold in most of the clinics across the world, surgeons are consulting their patients via telemedicine. Some surgeons are expecting an initial rush once the clinic reopens due to backlog cases, however, in the long run, they predict changes in the near future. There will also be an additional impact on revenue. With deep sanitization and PPEs to be worn for even injectable procedures, small businesses are expected to undergo the overhead expense and a decreased revenue, many could even shut down.

Facial Injectable Market Report Highlights

• By product, the botulinum toxin type A segment led the market in 2020 and is projected to dominate throughout the forecast period. It is one of the most popularly used minimally invasive procedures

• Based on application, the aesthetics segment is projected to be the fastest-growing segment over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures, such as the treatment of wrinkles on the face

• North America dominated the market in 2020 with a share of over 41.0% owing to the easy availability of the products and the presence of a large number of skilled surgeons

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
Chapter 3. Facial Injectable Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing beauty consciousness among consumers
3.2.1.2. Shift in consumer preference toward minimally invasive procedures
3.2.2. Market Restraint Analysis
3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat from new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Social Landscape
3.3.2.3. Technology Landscape
3.3.2.4. Legal Landscape
Chapter 4. Facial Injectable Market: Segment Analysis, By Product, 2016 – 2028 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2020 & 2028
4.3. Global Facial Injectable Market, By Product, 2016 – 2028
4.4. Market Size & Forecasts and Trend Analysis, 2016 – 2028 for the following
4.4.1. Collagen
4.4.2. Botulinum Toxin Type A
4.4.3. Hyaluronic Acid (HA)
4.4.4. Calcium Hydroxylapatite (CaHA)
4.4.5. Polymer Fillers
4.4.5.1. Polymethylmethacrylate beads (PMMA Microspheres)
4.4.5.2. Poly-L-Lactic Acid (PLLA)
Chapter 5. Facial Injectable Market: Segment Analysis, By Application, 2016 – 2028 (USD Million)
5.1. Definitions & Scope
5.2. Application market share analysis, 2020 & 2028
5.3. Global Facial Injectable Market, By Application, 2016 – 2028
5.4. Market Size & Forecasts and Trend Analysis, 2016 – 2028 for the following
5.4.1. Aesthetics
5.4.2. Therapeutics
Chapter 6. Facial Injectable Market: Regional Market Analysis, By Region, 2016 – 2028 (USD Million)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2020 & 2028
6.3. Regional Market Dashboard
6.4. Market Size, & Forecasts, and Trend Analysis, 2020 to 2028:
6.5. North America
6.5.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.5.2. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.5.3. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.5.4. U.S.
6.5.4.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.5.4.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.5.5. Canada
6.5.5.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.5.5.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6. Europe
6.6.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.6.2. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.3. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.4. Germany
6.6.4.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.4.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.5. U.K.
6.6.5.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.5.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.6. France
6.6.6.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.6.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.7. Italy
6.6.7.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.7.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.8. Spain
6.6.8.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.8.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.9. Switzerland
6.6.9.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.9.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.10. Netherlands
6.6.10.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.10.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.6.11. Belgium
6.6.11.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.6.11.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7. Asia Pacific
6.7.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.7.2. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.3. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.4. China
6.7.4.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.4.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.5. Japan
6.7.5.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.5.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.6. India
6.7.6.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.6.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.7. Thailand
6.7.7.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.7.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.8. South Korea
6.7.8.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.8.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.9. Australia
6.7.9.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.9.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.10. Malaysia
6.7.10.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.10.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.11. Singapore
6.7.11.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.11.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.12. Indonesia
6.7.12.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.12.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.7.13. Philippines
6.7.13.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.7.13.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.8. Latin America
6.8.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.8.2. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.8.3. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.8.4. Brazil
6.8.4.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.8.4.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.8.5. Mexico
6.8.5.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.8.5.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.8.6. Argentina
6.8.6.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.8.6.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.8.7. Colombia
6.8.7.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.8.7.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.8.8. Chile
6.8.8.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.8.8.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.9. Middle East and Africa
6.9.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.9.2. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.9.2.1. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.9.3. South Africa
6.9.3.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.9.3.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.9.4. Saudi Arabia
6.9.4.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.9.4.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.9.5. UAE
6.9.5.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.9.5.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.9.6. Israel
6.9.6.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.9.6.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
6.9.7. Turkey
6.9.7.1. Market estimates and forecast, by product, 2016 – 2028 (USD Million)
6.9.7.2. Market estimates and forecast, by application, 2016 – 2028 (USD Million)
Chapter 7. Facial Injectable Market – Competitive Analysis
7.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
7.2. Vendor Landscape
7.2.1. List of key distributors and channel partners
7.3. Key companies profiled
7.3.1. ALLERGAN
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Product Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Ipsen
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Product Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Merz Pharma
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Product Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Suneva Medical, Inc.
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Product Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Medytox Inc.
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Product Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Sinclair Pharma
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Product Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Bloomage BioTechnology Corporation Limited
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Product Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Anika Therapeutics, Inc.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Product Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Prollenium Medical Technologies Inc.
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Product Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Galderma S.A.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives.

List of Tables

Table 1 Global facial injectable market, by region, 2016 - 2028 (USD Million)
Table 2 Global facial injectable market, by product, 2016 - 2028 (USD Million)
Table 3 Global facial injectable market, by application, 2016 - 2028 (USD Million)
Table 4 North America facial injectable market, by country, 2016 - 2028 (USD Million)
Table 5 North America facial injectable market, by product, 2016 - 2028 (USD Million)
Table 6 North America facial injectable market, by application, 2016 - 2028 (USD Million)
Table 7 U.S. facial injectable market, by product, 2016 - 2028 (USD Million)
Table 8 U.S. facial injectable market, by application, 2016 - 2028 (USD Million)
Table 9 Canada facial injectable market, by product, 2016 - 2028 (USD Million)
Table 10 Canada facial injectable market, by application, 2016 - 2028 (USD Million)
Table 11 Europe facial injectable market, by country, 2016 - 2028 (USD Million)
Table 12 Europe facial injectable market, by product, 2016 - 2028 (USD Million)
Table 13 Europe facial injectable market, by application, 2016 - 2028 (USD Million)
Table 14 U.K. facial injectable market, by product, 2016 - 2028 (USD Million)
Table 15 U.K. facial injectable market, by application, 2016 - 2028 (USD Million)
Table 16 Germany facial injectable market, by product, 2016 - 2028 (USD Million)
Table 17 Germany facial injectable market, by application, 2016 - 2028 (USD Million)
Table 18 France facial injectable market, by product, 2016 - 2028 (USD Million)
Table 19 France facial injectable market, by application, 2016 - 2028 (USD Million)
Table 20 Italy facial injectable market, by product, 2016 - 2028 (USD Million)
Table 21 Italy facial injectable market, by application, 2016 - 2028 (USD Million)
Table 22 Spain facial injectable market, by product, 2016 - 2028 (USD Million)
Table 23 Spain facial injectable market, by application, 2016 - 2028 (USD Million)
Table 24 Switzerland facial injectable market, by product, 2016 - 2028 (USD Million)
Table 25 Switzerland facial injectable market, by application, 2016 - 2028 (USD Million)
Table 26 Netherlands facial injectable market, by product, 2016 - 2028 (USD Million)
Table 27 Netherlands facial injectable market, by application, 2016 - 2028 (USD Million)
Table 28 Belgium facial injectable market, by product, 2016 - 2028 (USD Million)
Table 29 Belgium facial injectable market, by application, 2016 - 2028 (USD Million)
Table 30 Asia Pacific facial injectable market, by product, 2016 - 2028 (USD Million)
Table 31 Asia Pacific facial injectable market, by application, 2016 - 2028 (USD Million)
Table 32 Japan Facial Injectable Market, by product, 2016 - 2028 (USD Million)
Table 33 Japan Facial Injectable Market, by application, 2016 - 2028 (USD Million)
Table 34 China facial injectable market, by product, 2016 - 2028 (USD Million)
Table 35 China facial injectable market, by application, 2016 - 2028 (USD Million)
Table 36 India facial injectable market, by product, 2016 - 2028 (USD Million)
Table 37 India facial injectable market, by application, 2016 - 2028 (USD Million)
Table 38 Thailand facial injectable market, by product, 2016 - 2028 (USD Million)
Table 39 Thailand facial injectable market, by application, 2016 - 2028 (USD Million)
Table 40 South Korea facial injectable market, by product, 2016 - 2028 (USD Million)
Table 41 South Korea facial injectable market, by application, 2016 - 2028 (USD Million)
Table 42 Australia facial injectable market, by product, 2016 - 2028 (USD Million)
Table 43 Australia facial injectable market, by application, 2016 - 2028 (USD Million)
Table 44 Malaysia facial injectable market, by product, 2016 - 2028 (USD Million)
Table 45 Malaysia facial injectable market, by application, 2016 - 2028 (USD Million)
Table 46 Singapore facial injectable market, by product, 2016 - 2028 (USD Million)
Table 47 Singapore facial injectable market, by application, 2016 - 2028 (USD Million)
Table 48 Indonesia facial injectable market, by product, 2016 - 2028 (USD Million)
Table 49 Indonesia facial injectable market, by application, 2016 - 2028 (USD Million)
Table 50 Philippines facial injectable market, by product, 2016 - 2028 (USD Million)
Table 51 Philippines facial injectable market, by application, 2016 - 2028 (USD Million)
Table 52 Latin America facial injectable market, by country, 2016 - 2028 (USD Million)
Table 53 Latin America facial injectable market, by product, 2016 - 2028 (USD Million)
Table 54 Latin America facial injectable market, by application, 2016 - 2028 (USD Million)
Table 55 Brazil facial injectable market, by product, 2016 - 2028 (USD Million)
Table 56 Brazil facial injectable market, by application, 2016 - 2028 (USD Million)
Table 57 Mexico facial injectable market, by product, 2016 - 2028 (USD Million)
Table 58 Mexico facial injectable market, by application, 2016 - 2028 (USD Million)
Table 59 Argentina facial injectable market, by product, 2016 - 2028 (USD Million)
Table 60 Argentina facial injectable market, by application, 2016 - 2028 (USD Million)
Table 61 Colombia facial injectable market, by product, 2016 - 2028 (USD Million)
Table 62 Colombia facial injectable market, by application, 2016 - 2028 (USD Million)
Table 63 Chile facial injectable market, by product, 2016 - 2028 (USD Million)
Table 64 Chile facial injectable market, by application, 2016 - 2028 (USD Million)
Table 65 Middle East & Africa facial injectable market, by country, 2016 - 2028 (USD Million)
Table 66 Middle East & Africa facial injectable market, by product, 2016 - 2028 (USD Million)
Table 67 Middle East & Africa facial injectable market, by application, 2016 - 2028 (USD Million)
Table 68 South Africa facial injectable market, by product, 2016 - 2028 (USD Million)
Table 69 South Africa facial injectable market, by application, 2016 - 2028 (USD Million)
Table 70 Saudi Arabia facial injectable market, by product, 2016 - 2028 (USD Million)
Table 71 Saudi Arabia facial injectable market, by application, 2016 - 2028 (USD Million)
Table 72 UAE facial injectable market, by product, 2016 - 2028 (USD Million)
Table 73 UAE facial injectable market, by application, 2016 - 2028 (USD Million)
Table 74 Israel facial injectable market, by product, 2016 - 2028 (USD Million)
Table 75 Israel facial injectable market, by application, 2016 - 2028 (USD Million)
Table 76 Turkey Facial Injectable Market, by product, 2016 - 2028 (USD Million)
Table 77 Turkey Facial Injectable Market, by application, 2016 - 2028 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Facial injectable market segmentation
Figure 9 Market driver relevance analysis (Current & future impact)
Figure 10 Market restraint relevance analysis (Current & future impact)
Figure 11 Market challenge relevance analysis (Current & future impact)
Figure 12 Penetration & growth prospect mapping
Figure 13 SWOT analysis, by factor (political & legal, economic and technological)
Figure 14 Porter’s five forces analysis
Figure 15 Market penetration vs growth prospect mapping
Figure 16 Facial injectable market: product movement analysis
Figure 17 Regional marketplace: Key takeaways
Figure 18 Regional outlook, 2020 & 2028
Figure 19 North America facial injectable market, 2016 - 2028 (USD Million)
Figure 20 U.S. facial injectable market, 2016 - 2028 (USD Million)
Figure 21 Canada facial injectable market, 2016 - 2028 (USD Million))
Figure 22 Europe facial injectable market, 2016 - 2028 (USD Million)
Figure 23 U.K. facial injectable market, 2016 - 2028 (USD Million)
Figure 24 Germany facial injectable market, 2016 - 2028 (USD Million)
Figure 25 Italy facial injectable market, 2016 - 2028 (USD Million)
Figure 26 Spain facial injectable market, 2016 - 2028 (USD Million)
Figure 27 France facial injectable market, 2016 - 2028 (USD Million)
Figure 28 Switzerland facial injectable market, 2016 - 2028 (USD Million)
Figure 29 Netherlands facial injectable market, 2016 - 2028 (USD Million)
Figure 30 Belgium facial injectable market, 2016 - 2028 (USD Million)
Figure 31 Asia Pacific facial injectable market, 2016 - 2028 (USD Million)
Figure 32 Japan facial injectable market, 2016 - 2028 (USD Million)
Figure 33 China facial injectable market, 2016 - 2028 (USD Million)
Figure 34 India facial injectable market, 2016 - 2028 (USD Million)
Figure 35 Thailand facial injectable market, 2016 - 2028 (USD Million)
Figure 36 South Korea facial injectable market, 2016 - 2028 (USD Million)
Figure 37 Australia facial injectable market, 2016 - 2028 (USD Million)
Figure 38 Malaysia facial injectable market, 2016 - 2028 (USD Million)
Figure 39 Singapore facial injectable market, 2016 - 2028 (USD Million)
Figure 40 Indonesia facial injectable market, 2016 - 2028 (USD Million)
Figure 41 Philippines facial injectable market, 2016 - 2028 (USD Million)
Figure 42 Latin America facial injectable market, 2016 - 2028 (USD Million)
Figure 43 Brazil facial injectable market, 2016 - 2028 (USD Million)
Figure 44 Mexico facial injectable market, 2016 - 2028 (USD Million)
Figure 45 Argentina facial injectable market, 2016 - 2028 (USD Million)
Figure 46 Colombia facial al injectable market, 2016 - 2028 (USD Million)
Figure 47 Chile facial al injectable market, 2016 - 2028 (USD Million)
Figure 48 MEA facial injectable market, 2016 - 2028 (USD Million)
Figure 49 South Africa facial injectable market, 2016 - 2028 (USD Million)
Figure 50 Saudi Arabia facial injectable market, 2016 - 2028 (USD Million)
Figure 51 UAE facial injectable market, 2016 - 2028 (USD Million)
Figure 52 Israel facial injectable market, 2016 - 2028 (USD Million)
Figure 53 Turkey facial injectable market, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の顔用注射剤市場2021-2028:製品別(コラーゲン、ヒアルロン酸、ボツリヌス毒素タイプA、ハイドロキシアパタイトカルシウム、ポリマーフィラー)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆